CONDENSED BICYCLIC COMPOUND Russian patent published in 2012 - IPC C07D265/16 C07D311/58 C07D413/04 A61K31/352 A61K31/536 A61P9/00 

Abstract RU 2468017 C2

FIELD: medicine.

SUBSTANCE: invention relates to condensed bicyclic compounds, having affinity with mineralocorticoid receptor (VR) of formula [I] and formula [ii], as well as to pharmaceutical compositions on their basis. In general formula [I[ and [ii] ring A represents benzene ring, which has substituent R1, condensed with adjacent 6-membered heterocyclic ring, and said benzene ring additionally optionally is substituted with one or two substituent(s), selected from halogen atom and C1-8-alkyl group, R1 represents C1-8-alkylsulfonyl amino group or C1-8-alkyl aminosulfonyl group, R2 and R3 (a) are similar or different and represent group, selected from hydrogen atom, C1-8-alkyl group, and from 6- to 10-membered monocyclic or bicyclic aryl group (said aryl group is optionally substituted with halogen atom), (b) are combined with each other with formation of oxogroup or (c) are combined with each other on their ends together with adjacent carbon atom with formation of C3-10-cycloalkyl group, X represents the following group =N-, =C(R4)- or -CH(R4)-, R4 represents hydrogen atom, cyanogroup, halogen atom, C1-6-alkyl group, C2-6-alkenyl group, C3-10-dicloalkyl group, C1-7-alkanoyl group, carbamoyl group or C3-8cycloalkenyl group, Ar represents from 6- to 10-membered monocyclic or bicyclic aryl group, optionally containing one or several heteroatom(s), selected from sulphur atom, oxygen atom and nitrogen atom (said aryl group is optionally substituted with similar or different, one or two substituent(s), selected from halogen atom, cyanogroup, C1-8-alkyl group, trihalogen- C1-8-alkyl group and C1-8alkoxygroup), and dotted line represents presence or absence of double bond, Xa represents the following group =N- or =C(CN)-, RZ represents hydrogen atom or halogen atom, R25 and R35 represent alkyl group, and Ar3 represents phenyl group, optionally substituted with one or two group(s), which is(are) selected from halogen atom and trihalogenalkyl group.

EFFECT: compounds can be applied as antihypertensive medication.

15 cl, 18 tbl, 8 dwg, 71 ex

Similar patents RU2468017C2

Title Year Author Number
NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS 2007
  • Iidzima Toru
  • Jamamoto Jasuo
  • Akatsuka Khidenori
  • Kavaguti Takajuki
RU2398769C2
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS 2005
  • Okhrai Kazukhiko
  • Sigeta Jukikhiro
  • Uesugi Osamu
  • Okada Takumi
  • Matsuda Tomojuki
RU2380370C2
USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE 2014
  • Okumura Takako
RU2663620C2
BENZOPYRAN DERIVATIVE 2005
  • Tsukagosi Toru
  • Nagatsuka Takajuki
  • Matsuda Tomojuki
  • Khasimoto Norio
RU2366658C2
USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES 2011
  • Kanazava Kijosi
  • Nonomura Kadzukhiko
  • Okumura Takako
  • Koidzumi Siniti
RU2571816C2
3-ALKYLIDENHYDRAZINO-HETEROARYL COMPOUNDS AS ACTIVATORS OF THROMBOPROTEIN RECEPTOR 2004
  • Ovada Singo
  • Ivamoto Sunsuke
  • Janagikhara Kazufumi
  • Mijadzi Katsuaki
  • Nakamura Takanori
  • Isivata Norikhisa
  • Khirokava Jutaka
RU2358970C2
NOVEL BICYCLIC HETEROCYCLIC COMPOUND 2009
  • Tsuboi Katsunori
  • Jamai Jusuke
  • Vatanabe Khitosi
  • Kinosita Khironori
RU2518073C2
3-ETHYLIDENEHYDRAZINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS 2005
  • Mijadzi Katsuaki
  • Sigeta Jukikhiro
  • Nakano Satosi
  • Ivamoto Sunsuke
  • Khirokava Jutaka
  • Ota Khirofumi
  • Janagikhara Kazufumi
  • Ovada Singo
  • Isivata Norikhisa
RU2395505C2
HETEROCYCLIC COMPOUND 2019
  • Ono, Koji
  • Ito, Masahiro
  • Tanaka, Toshio
  • Asano, Moriteru
  • Hirayama, Takaharu
  • Fujimoto, Jun
  • Sakauchi, Nobuki
  • Hirata, Yasuhiro
  • Toita, Akinori
  • Morishita, Nao
  • Kokubo, Hironori
  • Imaeda, Yasuhiro
  • Maezaki, Hironobu
  • Cary, Douglas Robert
  • Mizojiri, Ryo
  • Cho, Nobuo
  • Banno, Hiroshi
  • Tokuhara, Hidekazu
  • Arikawa, Yasuyoshi
RU2815003C2
1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORS 2005
  • Bilodo Mark T.
  • U. Chzhitsaj
  • Khartnett Dzhon
RU2344134C2

RU 2 468 017 C2

Authors

Takakhasi Eiti

Avai Nobumasa

Akatsuka Khidenori

Kavaguti Takajuki

Iidzima Toru

Dates

2012-11-27Published

2008-07-31Filed